High level of resistance to levofloxacin of Streptococcus pneumoniae following fluoroquinolone therapy.
d'Escrivan
T
T
Roussel-Delvallez
M
M
Alfandari
S
S
Guery
B
B
D000368:Aged; D002439:Cefotaxime / Q000008:administration & dosage*; D017714:Community-Acquired Infections / Q000175:diagnosis / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004352:Drug Resistance, Microbial; D005500:Follow-Up Studies; D006801:Humans; D007262:Infusions, Intravenous; D064704:Levofloxacin; D008297:Male; D008826:Microbial Sensitivity Tests; D015242:Ofloxacin / Q000494:pharmacology*; D011018:Pneumonia, Pneumococcal / Q000175:diagnosis / Q000188:drug therapy*; D018570:Risk Assessment; D012720:Severity of Illness Index; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000302:isolation & purification; D016896:Treatment Outcome
D064704:Levofloxacin; D015242:Ofloxacin; D002439:Cefotaxime